/Resmed%20Inc_%20HQ%20photo-by%20JHVEPhoto%20via%20iStock.jpg)
ResMed Inc. (RMD), headquartered in San Diego, California, specializes in designing and delivering medical devices and cloud-connected software for the healthcare sector. With a market cap of $33.6 billion, the company’s core offerings include masks, ventilators, and accessories aimed at treating sleep-disordered breathing (SDB) and various respiratory conditions. ResMed is set to report its fiscal Q3 earnings on Wednesday, April 23.
Ahead of the event, analysts project the medical instruments provider to report a profit of $2.36 per share, up 10.8% from $2.13 per share in the year-ago quarter. Moreover, the company has consistently beaten Wall Street's bottom-line estimates in all of the last four quarters.